Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Pär Stattin"'
Publikováno v:
International Journal of Cancer. 151:1925-1934
Androgen deprivation therapy (ADT) has been hypothesized to protect against COVID-19, but previous observational studies of men with prostate cancer on ADT have been inconsistent regarding mortality risk from coronavirus disease 2019 (COVID-19). Usin
Autor:
Eleanor L, Watts, Aurora, Perez-Cornago, Georgina K, Fensom, Karl, Smith-Byrne, Urwah, Noor, Colm D, Andrews, Marc J, Gunter, Michael V, Holmes, Richard M, Martin, Konstantinos K, Tsilidis, Demetrius, Albanes, Aurelio, Barricarte, Bas, Bueno-de-Mesquita, Chu, Chen, Barbara A, Cohn, Niki L, Dimou, Luigi, Ferrucci, Leon, Flicker, Neal D, Freedman, Graham G, Giles, Edward L, Giovannucci, Gary E, Goodman, Christopher A, Haiman, Graeme J, Hankey, Jiaqi, Huang, Wen-Yi, Huang, Lauren M, Hurwitz, Rudolf, Kaaks, Paul, Knekt, Tatsuhiko, Kubo, Hilde, Langseth, Gail, Laughlin, Loic, Le Marchand, Tapio, Luostarinen, Robert J, MacInnis, Hanna O, Mäenpää, Satu, Männistö, E Jeffrey, Metter, Kazuya, Mikami, Lorelei A, Mucci, Anja W, Olsen, Kotaro, Ozasa, Domenico, Palli, Kathryn L, Penney, Elizabeth A, Platz, Harri, Rissanen, Norie, Sawada, Jeannette M, Schenk, Pär, Stattin, Akiko, Tamakoshi, Elin, Thysell, Chiaojung Jillian, Tsai, Shoichiro, Tsugane, Lars, Vatten, Elisabete, Weiderpass, Stephanie J, Weinstein, Lynne R, Wilkens, Bu B, Yeap, Naomi E, Allen, Timothy J, Key, Ruth C, Travis
Publikováno v:
Watts, E L, Martin, R M & the PRACTICAL Consortium 2022, ' Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia ', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046 . https://doi.org/10.1002/ijc.34116
International Journal of Cancer
Watts, E L, Perez-Cornago, A, Fensom, G K, Smith-Byrne, K, Noor, U, Andrews, C D, Gunter, M J, Holmes, M V, Martin, R M, Tsilidis, K K, Albanes, D, Barricarte, A, Bueno-de-Mesquita, H B, Chen, C, Cohn, B A, Dimou, N L, Ferrucci, L, Flicker, L, Freedman, N D, Giles, G G, Giovannucci, E L, Goodman, G E, Haiman, C A, Hankey, G J, Huang, J, Huang, W-Y, Hurwitz, L M, Kaaks, R, Knekt, P, Kubo, T, Langseth, H, Laughlin, G, Le Marchand, L, Luostarinen, T, MacInnis, R J, Mäenpää, H O, Männistö, S, Metter, E J, Mikami, K, Mucci, L A, Olsen, A W, Ozasa, K, Palli, D, Penney, K L, Platz, E A, Rissanen, H, Sawada, N, Schenk, J M, Stattin, P, PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS & Tamakoshi, A 2022, ' Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia ', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046 . https://doi.org/10.1002/ijc.34116
International Journal of Cancer
Watts, E L, Perez-Cornago, A, Fensom, G K, Smith-Byrne, K, Noor, U, Andrews, C D, Gunter, M J, Holmes, M V, Martin, R M, Tsilidis, K K, Albanes, D, Barricarte, A, Bueno-de-Mesquita, H B, Chen, C, Cohn, B A, Dimou, N L, Ferrucci, L, Flicker, L, Freedman, N D, Giles, G G, Giovannucci, E L, Goodman, G E, Haiman, C A, Hankey, G J, Huang, J, Huang, W-Y, Hurwitz, L M, Kaaks, R, Knekt, P, Kubo, T, Langseth, H, Laughlin, G, Le Marchand, L, Luostarinen, T, MacInnis, R J, Mäenpää, H O, Männistö, S, Metter, E J, Mikami, K, Mucci, L A, Olsen, A W, Ozasa, K, Palli, D, Penney, K L, Platz, E A, Rissanen, H, Sawada, N, Schenk, J M, Stattin, P, PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS & Tamakoshi, A 2022, ' Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia ', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046 . https://doi.org/10.1002/ijc.34116
Publisher Copyright: © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. Previous studies had limited power to assess the associations of testosterone with aggressive disease as a primary endpoin
Autor:
Steinar Tretli, Tanja Stocks, Hanno Ulmer, Marju Orho-Melander, Jonas Manjer, Christel Häggström, Stanley Teleka, Håkan Jonsson, Fredrik Liedberg, Staffan Jahnson, Tone Bjørge, Alois Lang, Pär Stattin, Gabriele Nagel, Sara Ghaderi
Publikováno v:
International Journal of Cancer. 143:3071-3082
Previous studies on metabolic factors and bladder cancer (BC) risk have shown inconsistent results and have commonly not investigated associations separately by sex, smoking, and tumor invasiveness ...
Autor:
Emily Sonestedt, Peter Wallström, Konstantinos K. Tsilidis, Isabel Drake, Shoichiro Tsugane, Pär Stattin, Kazuya Mikami, Robert Luben, Antonia Trichopoulou, Aurora Perez-Cornago, Paul N. Appleby, Norie Sawada, Tatsuhiko Kubo, Ruth C. Travis, Fulvio Ricceri, Leire Gil, Anders Johansson, Rikard Landberg, Cecilie Kyrø, Akiko Tamakoshi, Hilde Langseth, Neil Murphy, Randi Elin Gislefoss, Naomi E. Allen, Heiner Boeing, Lena Maria Nilsson, Kay-Tee Khaw, Kotaro Ozasa, Timothy J. Key
Publikováno v:
International Journal of Cancer. 143:2677-2686
Phytoestrogens may influence prostate cancer development. This study aimed to examine the association between prediagnostic circulating concentrations of isoflavones (genistein, daidzein, equol) and lignans (enterolactone and enterodiol) and the risk
Autor:
Robert Williams, Håkan Malmström, David Robinsson, Mats Lambe, Hans Garmo, Lars Holmberg, Pär Stattin, M. Van Hemelrijck, Ingmar Jungner, Niklas Hammar, Rhonda Arthur, Göran Walldius
Publikováno v:
International Journal of Cancer. 142:2254-2262
Inflammation is a well-documented driver of cancer development and progression. However, little is known about its role in prostate carcinogenesis. Thus, we examined the association of C-reactive protein (CRP), haptoglobin, albumin and white blood ce
Autor:
Birgitta Grundmark, David Robinson, Mieke Van Hemelrijck, Christel Häggström, Lars Holmberg, Hans Garmo, Pär Stattin, Björn Zethelius, Soffia Gudbjörnsdottir
Publikováno v:
International Journal of Cancer. 140:611-617
Type 2 diabetes mellitus (T2DM) has consistently been associated with decreased risk of prostate cancer; however, if this decrease is related to the use of anti-diabetic drugs is unknown. We prospe ...
Autor:
Sarah C. Markt, Caroline Nordenvall, Jennifer R. Rider, Fang Fang, Kathryn M. Wilson, Pär Stattin, Hans-Olov Adami, Lorelei A. Mucci, Weimin Ye, Olof Nyrén
Publikováno v:
International Journal of Cancer. 139:2753-2759
Smoking is associated with prostate cancer mortality. The Scandinavian smokeless tobacco product snus is a source of nicotine but not the combustion products of smoke and has not been studied with ...
Autor:
Hans Garmo, Pär Stattin, Christian Ingvar, Yasin Folkvaljon, Stacy Loeb, Frederik Birkebæk Thomsen, David Robinson, Mats Lambe
Publikováno v:
International Journal of Cancer. 138:2154-2160
An increased risk of malignant melanoma has been observed in men with prostate cancer. To assess potential shared risk factors and confounding factors, we analysed risk of melanoma in men with prostate cancer including information on tumor characteri
Autor:
Stanley, Teleka, Christel, Häggström, Gabriele, Nagel, Tone, Bjørge, Jonas, Manjer, Hanno, Ulmer, Fredrik, Liedberg, Sara, Ghaderi, Alois, Lang, Håkan, Jonsson, Staffan, Jahnson, Marju, Orho-Melander, Steinar, Tretli, Pär, Stattin, Tanja, Stocks
Publikováno v:
International journal of cancer. 143(12)
Previous studies on metabolic factors and bladder cancer (BC) risk have shown inconsistent results and have commonly not investigated associations separately by sex, smoking, and tumor invasiveness. Among 811,633 participants in six European cohorts,
Autor:
Mattias Johansson, Kim Overvad, Diana Gavrila Chervase, Elio Riboli, Kay-Tee Khaw, Johan Malm, Pagona Lagiou, J. Ramón Quirós, Eva Ardanaz, Ute Nöthlings, Marc J. Gunter, Veronique Chajes, Larraitz Arriola, Naomi E. Allen, Domenico Palli, Dimitrios Trichopoulos, Rudolf Kaaks, Esther Molina-Montes, Sabine Rohrmann, Pär Stattin, Ruth C. Travis, Nicholas J. Wareham, Nina Roswall, Ana Fonseca-Nunes, Anne Tjønneland, Isabelle Romieu, Heiner Boeing, Sabina Rinaldi, Konstantinos K. Tsilidis, Valeria Pala, Tobias Pischon, Ioanna Tzoulaki, Paul N. Appleby, Rosario Tumino, Neil Murphy, Annekatrin Lukanova, Antonia Trichopoulou, H. Bas Bueno-de-Mesquita, Christina C. Dahm, Paolo Vineis, Marju Orho-Melander, Timothy J. Key
Publikováno v:
International Journal of Cancer. 136:372-381
The current epidemiologic evidence suggests that men with type 2 diabetes mellitus may be at lower risk of developing prostate cancer, but little is known about its association with stage and grade of the disease. The association between self-reporte